Stay updated on Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedLocations section updated: the previous list of locations (Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Indiana, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Manitoba, Ontario, Quebec) was removed and replaced with a new set of locations. Revision: v3.3.3 has been added.SummaryDifference2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedAdded language clarifying that some publications are provided voluntarily and that others are automatically filled from PubMed. Updated the revision to v3.3.2 and removed older wording about automatic publication creation from PubMed using the NCT number.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding/operating status banner at the top of the page was removed. All other study details and sections remain unchanged.SummaryDifference0.2%

- Check61 days agoChange DetectedCore study information, eligibility criteria, and locations appear unchanged between screenshots. Differences are cosmetic and do not affect the study's content or enrollment.SummaryDifference0.3%

- Check89 days agoChange DetectedAdded a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference3%

- Check97 days agoChange DetectedUpdate to a newer software version (from v3.0.2 to v3.1.0); the page now reflects the latest revision identifier.SummaryDifference0.1%

Stay in the know with updates to Tapinarof Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tapinarof Efficacy in Atopic Dermatitis Clinical Trial page.